Shoko Ohno

411 total citations
14 papers, 326 citations indexed

About

Shoko Ohno is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Shoko Ohno has authored 14 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 2 papers in Surgery. Recurrent topics in Shoko Ohno's work include Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Connective Tissue Growth Factor Research (3 papers). Shoko Ohno is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Connective Tissue Growth Factor Research (3 papers). Shoko Ohno collaborates with scholars based in Japan, United Kingdom and Germany. Shoko Ohno's co-authors include Hideki Yokoi, Akira Ishii, Motoko Yanagita, Keita Mori, Masashi Mukoyama, Yukiko Kato, Takashige Kuwabara, Masato Kasahara, Kazuwa Nakao and Kiyoshi Mori and has published in prestigious journals such as Scientific Reports, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Shoko Ohno

14 papers receiving 323 citations

Peers

Countries citing papers authored by Shoko Ohno

Since Specialization

Citations

This map shows the geographic impact of Shoko Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoko Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoko Ohno more than expected).

Fields of papers citing papers by Shoko Ohno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoko Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoko Ohno. The network helps show where Shoko Ohno may publish in the future.

Co-authorship network of co-authors of Shoko Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of Shoko Ohno. A scholar is included among the top collaborators of Shoko Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoko Ohno. Shoko Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), Hiroyuki Yamada, (unknown), Akira Ishii, Naohiro Toda, Shoko Ohno, Yukiko Kato, (unknown), Motoko Yanagita, Hideki Yokoi	1
2	Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFκΒ pathway inhibition 2023 ·Kidney International ·(unknown), Akira Ishii, Hiroyuki Yamada, (unknown), Naohiro Toda, Keita Mori, Shoko Ohno, Yukiko Kato, (unknown), (unknown), (unknown), (unknown), Motoko Yanagita, Hideki Yokoi	11
3	Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess 2023 ·Nephrology Dialysis Transplantation ·(unknown), Akira Ishii, Hiroyuki Yamada, Keita Mori, Yukiko Kato, Shoko Ohno, (unknown), (unknown), (unknown), (unknown), (unknown), Naoto Minamino, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi	11
4	Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi 2023 ·Kidney International ·(unknown), Hiroyuki Yamada, Akira Ishii, (unknown), Ryo Yamada, Keita Mori, Shoko Ohno, (unknown), (unknown), (unknown), (unknown), Takeshi Tokudome, Taiji Matsusaka, Ángel R. Nebreda, Motoko Yanagita, Hideki Yokoi	4
5	Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition 2021 ·Scientific Reports ·(unknown), Keita Mori, Akira Ishii, Shoko Ohno, Yugo Kanai, Haruko Watanabe‐Takano, Akihiro Yasoda, Takashige Kuwabara, Nobuyuki Takahashi, Naoki Mochizuki, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi	6
6	Calcium channel blocker in patients with chronic kidney disease 2021 ·Clinical and Experimental Nephrology ·Shoko Ohno, Akira Ishii, Motoko Yanagita, Hideki Yokoi	11
7	Crucial Role of Mesangial Cell-derived Connective Tissue Growth Factor in a Mouse Model of Anti-Glomerular Basement Membrane Glomerulonephritis 2017 ·Scientific Reports ·Naohiro Toda, Kiyoshi Mori, Masato Kasahara, Akira Ishii, Kenichi Koga, Shoko Ohno, Keita Mori, Yukiko Kato, (unknown), Takashige Kuwabara, (unknown), Daisuke Taura, Masakatsu Sone, Taiji Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi	27
8	Procyanidins from Cinnamomi Cortex promote proteasome-independent degradation of nuclear Nrf2 through phosphorylation of insulin-like growth factor-1 receptor in A549 cells 2017 ·Archives of Biochemistry and Biophysics ·Tomokazu Ohnuma, (unknown), (unknown), (unknown), Shoko Ohno, Takahito Nishiyama, Kenichiro Ogura, Akira Hiratsuka	18
9	Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition 2017 ·Scientific Reports ·Yukiko Kato, Kiyoshi Mori, Masato Kasahara, (unknown), Akira Ishii, Keita Mori, Naohiro Toda, Shoko Ohno, Takashige Kuwabara, Takeshi Tokudome, Ichiro Kishimoto, Moin A. Saleem, Taiji Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi	17
10	Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure 2016 ·Scientific Reports ·Shoko Ohno, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Koichiro Kuwahara, Junji Fujikura, (unknown), Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Moin A. Saleem, Tomohiro Numata, Yasuo Mori, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama	18
11	Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy 2016 ·Journal of the American Society of Nephrology ·Keita Mori, Hideki Yokoi, Masato Kasahara, Hirotaka Imamaki, Akira Ishii, Takashige Kuwabara, Kenichi Koga, Yukiko Kato, Naohiro Toda, Shoko Ohno, Koichiro Kuwahara, Tomomi Endo, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama, Kiyoshi Mori	59
12	MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy 2015 ·Diabetologia ·Kenichi Koga, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Keita Mori, Yukiko Kato, Shoko Ohno, Naohiro Toda, Moin A. Saleem, Akira Sugawara, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama	85
13	Glomerular Endotheliosis in a Pregnant Woman with Severe Gestational Proteinuria 2013 ·Internal Medicine ·(unknown), Kensei Yahata, Shoko Ohno, Kenichi Koga, Yūko Kikuchi, (unknown), Koichi Seta, Takashi Kuwahara, Akira Sugawara	4
14	Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis 2011 ·Kidney International ·Hideki Yokoi, Masato Kasahara, Kiyoshi Mori, Yoshihisa Ogawa, Takashige Kuwabara, Hirotaka Imamaki, (unknown), Kenichi Koga, Akira Ishii, Yukiko Kato, Keita Mori, Naohiro Toda, Shoko Ohno, Hisako Muramatsu, Takashi Muramatsu, Akira Sugawara, Masashi Mukoyama, Kazuwa Nakao	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhimei Lv Breakdown of academic impact, for papers by Yudong Fang Breakdown of academic impact, for papers by Houyong Dai Breakdown of academic impact, for papers by Ruonan Zhai Breakdown of academic impact, for papers by Yanqing Jiang Breakdown of academic impact, for papers by Bridgit B. Bowskill Breakdown of academic impact, for papers by Kenichi Koga Breakdown of academic impact, for papers by Kurt Gleich